This document lists various medical conditions, diseases, cancers, infections, medical devices, pharmaceuticals, and healthcare services. It also outlines Healthios' experience providing strategic advisory services to companies across these areas, including facilitating financings, mergers and acquisitions, partnerships, and other strategic initiatives.

1. Diabetic Nephropathy
Diabetic Retinopathy
Hypercholesterolemia
Oral Mucositis
Gout
Acute Lymphocytic Leukemia
Bone Metastasis
Brain Cancer
Breast Cancer
Cervical Cancer
Chronic Lymphocytic Leukemia
Endometrial Cancer
Ewing Sarcoma
Gastric Cancer
Gastrointestinal Stromal Tumors
Head And Neck Cancer
Hodgkin Lymphoma
Kidney Cancer
Liver Cancer
Malignant Mesothelioma
Medullary Thyroid Cancer
Melanoma
Multiple Myeloma
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Testicular Cancer
Thyroid Cancer
Age Related Macular Degeneration
Keratoconjunctivitis sicca (Dry Eye)
Retinal Vein Occlusion
Acute Respiratory Distress
Syndrome
Sepsis
Staphylococcal Infections
Acute Coronary Syndrome
Angina Pectoris
Atrial Fibrillation
Coronary Artery Disease (CAD)
Critical Limb Ischemia
Hypertension
Pulmonary Arterial Hypertension
Acute Pain
Anxiety Disorders
Chronic Pain
Dementia
Diabetic Neuropathy
Obsessive-Compulsive Disorder
Osteoarthritis Pain
Parkinson's Disease
Post-Traumatic Stress Disorder
Restless Legs Syndrome
Schizophrenia
Traumatic Brain Injury
Liver Cirrhosis
Childhood Enuresis
Growth Hormone Disorders
Hyperparathyroidism
Hyperthyroidism
Guillain-Barre Syndrome
Cytomegalovirus
Fungal Infections
Gram-Negative Bacterial Infections
H1N1 Infection
Herpes Zoster
HIV-1 Infection
Human Papillomavirus Infections
Staphylococcus Aureus (MRSA)
Cardiovascular Devices
Prosthetic Heart Valve
Peripheral Vascular Devices
Cardiovascular Monitoring & Diagnostic Devices
Cardiovascular Surgery
Cardiac Rhythm Management
Cardiovascular Prosthetic Devices
Interventional Cardiology
Cardiac Assist Devices
Wound Care Management
Hospital Supplies
Syringes and Needles
Disposable Hospital & Surgical Supplies
Drug Delivery Devices
Inhalation Systems
Needle Free Injections
Infusion Systems
Diabetes Care Devices
Insulin Delivery & Glucose Monitoring
Ophthalmic Devices
Cataract Surgery Devices
Ophthalmic Diagnostic Equipment
Refractive Surgery Devices
ENT Devices
Hearing Implants
Diagnostic Devices
Electrosurgical Devices
Dental Equipment & Accessories
Diagnostic Imaging & MRI Systems
C/T Systems & Mammography Equipment
X-Ray & Ultrasound Systems
Nuclear Imaging Equipment
Contrast Media Injectors
Bone Densitometry
Anesthesia and Respiratory Devices
Anesthesia Machines & Disposables
Respiratory Devices & Disposables
Sleep Apnea Diagnostic Systems
Healthcare IT
Medical Imaging Information Systems
Nephrology and Urology Devices
Renal Dialysis Equipment
Orthopedic Devices
Orthobiologics & Arthroscopy
Joint Reconstruction
Trauma Fixation
Orthopedic Prosthetics
Cranium Maxillofacial Fixation (CMF)
Spinal Surgery
Endoscopy Devices & instruments
Rigid & Flexible Endoscope
In Vitro Diagnostics
Genetic Testing
Clinical Chemistry
Hematology
Immuno Chemistry
Infectious Immunology
Histology And Cytology
Patient Monitoring
Multiparameter Patient Monitoring
Micro-Electromechanical Systems
Non-invasive Blood Pressure Monitors
Neurology Devices
Neurostimulation Devices
Interventional Neurology
CSF Management
Neurosurgical Products
Radiosurgery
Capital Markets
&
Transaction Experience

2. Research. Investment Banking. Healthcare.
Healthios Experience
2
Has completed multiple strategic
initiatives
BIOSPHERE MEDICAL, INC.
THE UNDERSIGNED HAS ACTED AS EXCLUSIVE
STRATEGIC ADVISOR TO BIOSPHERE
CHEETAH MEDICAL LTD.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO CHEETAH
Has completed its $20,000,000
Series B financing
Has completed multiple strategic
sales and marketing initiatives
PATHWAY MEDICAL
TECHNOLOGIES, INC.
THE UNDERSIGNED HAS ACTED AS EXCLUSIVE
STRATEGIC ADVISOR TO PATHWAY
TRIREME MEDICAL, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO TRIREME
Has completed its $17,000,000
Series D financing
Has sold certain emphysema assets to
THE UNDERSIGNED ACTED AS EXCULSIVE
ADVISOR TO BRONCUS
BRONCUS TECHNOLOGIES, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO TRIREME
Has entered into an exclusive
distribution agreement with
TRIREME MEDICAL, INC.
Has completed a review of various divestiture
and strategic financing alternatives
NOVADAQ TECHNOLOGIES, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO NOVADAQ
Has completed its $11,000,000
Series D financing
SYNCARDIA SYSTEMS, INC.
THE UNDERSIGNED ACTED AS ADVISOR
TO SYNCARDIA
Medical Devices & Diagnostics

3. Research. Investment Banking. Healthcare.
Medical Devices & Diagnostics
Healthios Experience
INNFOCUS, LLC
THE UNDERSIGNED ACTED AS EXCULSIVE
FINANCIAL ADVISOR TO INNFOCUS
Has completed a structured financing with
Has completed its
Series A financing
NEOCHORD, INC.
THE UNDERSIGNED ACTED AS
FINANCIAL ADVISOR TO NEOCHORD
CARDIOSOUTIONS, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO CARDIOSOLUTIONS
Has completed its $15,000,000
Series B financing led by
THE UNDERSIGNED ACTED AS FINANCIAL
ADVISOR TO CLAROS DIAGNOSTICS
Has been acquired by
CLAROS DIAGNOSTICS, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO DEERAC FLUIDICS
Has been acquired by
DEERAC FLUIDICS, INC.
Has been acquired by
THE UNDERSIGNED ACTED AS EXCULSIVE
FINANCIAL ADVISOR TO BRONCUS
BRONCUS TECHNOLOGIES, INC.
BOSTON SCIENTIFIC, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO CLAYTON DUBILIER & RICE
Has completed a strategic review of its
endoscopy business unit leading to its
decision to optimize strategic alternatives
through a tax-efficient “spin-off”
Has entered a Worldwide
Commercialization Partnership with
THE UNDERSIGNED ACTED AS EXCLUSIVE
FIANCIAL ADVISOR TO VERAX BIOMEDICAL
V BERAX IOMEDICAL
I N C O R P O R A T E D
VERAX BIOMEDICAL, INC.
3

4. Research. Investment Banking. Healthcare.
Medical Devices & Diagnostics
Healthios Experience
4
CLEARCOUNT MEDICAL
SOLUTIONS, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO CLEARCOUNT MEDICAL SOLUTIONS
Has licensed various IP to Has been acquired by
VENTUS MEDICAL, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO VENTUS MEDICAL
EXAGEN DIAGNOSTICS, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO EXAGEN DIAGNOSTICS
Has completed its $25,000,000
Debt financing
CRITICAL PERFUSION, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO CLEARCOUNT MEDICAL SOLUTIONS
Has entered into a co-development
agreement with
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO CLEARCOUNT MEDICAL SOLUTIONS
MIACOM DIAGNOSTICS
Has completed its equity financing from
NANOMIX, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO NANOMIX
Has completed its $12,000,000
Equity financing by strategic and
financial investors
Has completed a
Strategic Investment by
BIOMERIX, INC.
THE UNDERSIGNED HAS ACTED AS EXCLUSIVE
STRATEGIC ADVISOR TO BIOMERIX

5. Research. Investment Banking. Healthcare.
Healthios Experience
ALPHA THERAPEUTICS, INC
Has been acquired by
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO MORGAN STANLEY
An operating division of
BAYER PLASMA, GmBH
Has been acquired by
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO MORGAN STANLEY
An operating division of
Cerberus, LLC
SORBENT THERAPEUTICS, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO SORBENT
Has completed its spinout from
Dow Chemical
BioPharmaceuticals
Has completed its $6,000,000
Series A financing
PINNACLE BIOLOGICS, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO PINNACLE
CORIUM INTERNATIONAL, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO CORIUM INTERNATIONAL
Has issued $35 million in
Interest-Bearing High Yield Securities
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO INSPIRATION
$259,000,000
Completed a strategic partnership with
INSPIRATION
BIOPHARMACEUTICALS, INC.
Has completed a global collaboration
with
THE UNDERSIGNED ACTED AS FINANCIAL
ADVISOR TO LIQUIDIA
LIQUIDIA TECHNOLOGIES, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO NOVALAR
$65,000,000
Has been acquired by
NOVALAR PHARMACEUTICALS, INC.
5

6. Research. Investment Banking. Healthcare.
Healthios Experience
BioPharmaceuticals
6
Has completed its $60,000,000
Series C Financing
DICERNA PHARMACEUTICALS, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO DICERNA
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO LIQUIDIA
Has completed a $25 ,000,000 Series
A Financing in conjunction with the
“spin –off” of certain assets and
sciences from Liquidia
ENVISIA THERAPEUTICS, INC.
Has completed a round of financing
IRX Therapeutics
THE UNDERSIGNED ACTED AS ADVISOR
TO IRX
THE UNDERSIGNED ACTED AS FINANCIAL
ADVISOR TO CORIUM
CORIUM INTERNATIONAL, INC.,
$52,000,000
Initial Public Offering
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO KALON
FDBU (a Fujifilm subsidiary) acquires
49% of the total membership interests in
Kalon

7. Research. Investment Banking. Healthcare.
Healthios Experience
7
Diabetes Management
STEADYMED, LTD
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO STEADYMED
Has issued $10,000,000
Series B Preferred Stock
ING BARING
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO ING BARING
Has completed an investment in
WELLDOC, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR WELLDOC
Has issued $10,000,000
Series A Preferred Stock
BAXTER INTERNATIONAL, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO BAXTER
Has completed a strategic review of its
dialysis business unit, including a market
study of the Wearable Kidney Market and
the Chronic Kidney Disease Market
WELLDOC, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO WELLDOC
Has completed a strategic partnership
with
CALIBRA MEDICAL, INC.
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO CALIBRA
Has issued $10,000,000
Senior Subordinated Debt
Has been acquired by
THE UNDERSIGNED ACTED AS EXCULSIVE
FINANCIAL ADVISOR TO CALIBRA
CALIBRA MEDICAL, INC.

8. Research. Investment Banking. Healthcare.
Healthios Experience
8
Digital Health
iMEDICA, INC
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO iMEDICA
Has completed a strategic partnership
with
ADVANTEDGE HEALTH SOLUTIONS
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO AHS
Has completed multiple strategic
initiatives
EPOCRATES, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO EPOCRATES
Has completed multiple strategic
initiatives
WELLDOC, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO WELLDOC
Has issued $10,000,000
Series B Preferred Stock
WELLDOC, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO WELLDOC
Has completed a strategic partnership
with
PULSE SYSTEMS
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO PULSE
Healthios has issued a fairness
opinion in conjunction with the
acquisition of Pulse Systems
SXC HEALTH SOLUTIONS, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO SXC HEALTH SOLUTIONS
Has expanded its management team and
Board of Directors with the addition of
several leaders with significant experience
in the global healthcare industry
PARTNERS OF THE UNDERSIGNED ACTED AS
PRINCIPALS TO INLIGHT
Has issued
INLIGHT, INC.
$39,000,000
Series B Preferred Stock

9. Research. Investment Banking. Healthcare.
Healthios Experience
9
Medical Surgical Products & Distribution
MOLNLYCKE HEALTHCARE, AG
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO CLAYTON DUBILIER & RICE
Has been acquired by
REGENT MEDICAL, PLC
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO MORGAN STANLEY
Has been acquired by
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO SMARTPILL
Has been acquired by
SMARTPILL, INC.
Has entered into an exclusive distribution
agreement with
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO QUANTUM OPS
QUANTUM OPS, LLC
ING BARING
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO ING BARING
Has completed an investment in
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO ORTHOCON
ORTHOCON, INC.
Has completed a comprehensive
review of strategic & financial
alternatives
ALINE
AESTHETICS
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO ALINE AESTHETICS
Has been acquired by
a wholly owned subsidiary of

10. Research. Investment Banking. Healthcare.
Healthios Experience
10
Renal
FRESENIUS MEDICAL CARE
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO METALMARK CAPITAL
Through the divestiture of certain assets
and the completion of a long-term
product supply agreement, has formed
RMS LIFELINE, INC
Has been acquired by
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO J.W. CHILDS
An operating division of
SORBENT THERAPEUTICS, INC.
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO SORBENT
Has issued $20,000,000
Series B Preferred Stock
DOW CHEMICAL, INC
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO DOW CHEMICAL
Through the “spin –off” of certain
assets and sciences, and through the
contribution of $20 million of capital
from leading institutions, has formed

11. Research. Investment Banking. Healthcare.
Healthios Experience
11
Healthcare Services
APOLLO HOSPITAL GROUP INDIA
A portfolio investment of
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO ONE EQUITY PARTNERS
Has appointed the senior management of
NCS HEALTHCARE, INC.
Has been acquired by
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO PALADIUM EQUITY PARTNERS
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO OSF HEALTHCARE
OSF HEALTHCARE
Has expanded its management team and
Board of Directors with the addition of
several leaders with significant experience
in the global healthcare industry
UPSTREAM REHABILITATION, LLC
THE UNDERSIGNED ACTED AS STRATEGIC
ADVISOR TO UPSTREAM REHABILITATION
Has been formed by management
in collaboration with
WELLFOUNT CORP.
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO WELLFOUNT
Has completed its $22,000,000 Debt
and Equity financing